Post – Hegel

English

Background: Targeted therapies (TTs) for breast cancer represent a significant therapeutic advance, but they are also associated with specific side effects that require rigorous clinical monitoring and appropriate supportive care. Recognized as a medical practice in France since 1998, homeopathy is used by 30% of oncology patients, making it the leading complementary therapy within French integrative oncology. Recent studies have reported high patient satisfaction rates (up to 80%) with its use for managing symptoms such as pain, fatigue, anxiety, and nausea.

Methodology: Based on the recommendations of the International Homeopathic Society for Supportive Care in Oncology, a review of the scientific literature, and their own clinical experience, the authors explore homeopathic care protocols specifically tailored to each of the new TTs.

Results and discussion: While TTs represent therapeutic progress, they demand comprehensive and high-quality care. Better tolerance of these innovative treatments contributes to improved adherence, quality of life, and ultimately survival. Owing to the absence of significant side effects and drug interactions, homeopathy offers a favorable safety profile, making it particularly relevant for targeted therapies with a narrow therapeutic index. Easy to implement, the therapeutic recommendations presented in this article are provided for guidance only and are not intended to replace individualized homeopathic consultations. Their purpose is to provide oncologists with limited training in homeopathy, as well as homeopathic physicians without specific expertise in oncology, with a prescribing tool that is both reliable and easily accessible. These recommendations are not intended to replace individualized prescriptions based on the principle of similitude specific to the homeopathic method but may serve to complement them. Clinical studies are necessary to evaluate the clinical benefits of these recommendations.